ArticleImmunotherapy2018

Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma.

Dipongkor Saha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.